Related Experiment Videos
Early changes in procalcitonin and C-reactive protein during continuous renal replacement therapy and their
Kubra Boydag Guvenc1, Ebru Guney Sahin2, Sirin Guven3
1Department of Pediatric Intensive Care, Health Science University, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey. kubrabydg@gmail.com.
Insights
Continuous renal replacement therapy (CRRT) affects biomarker levels in critically ill children. Early procalcitonin (PCT) and C-reactive protein (CRP) kinetics showed limited ability to predict mortality, suggesting they are supportive, not standalone, prognostic tools.
Area of Science:
- Pediatric Critical Care Medicine
- Biomarker Kinetics
- Renal Replacement Therapy
Background:
- Continuous renal replacement therapy (CRRT) can alter biomarker levels in critically ill children.
- Accurate interpretation of biomarkers like procalcitonin (PCT) and C-reactive protein (CRP) is challenging during CRRT.
- Understanding early biomarker changes is crucial for prognostic assessment in pediatric intensive care.
Purpose of the Study:
- To characterize the early kinetics of PCT and CRP within 24 hours of CRRT initiation in critically ill children.
- To assess the association between early PCT and CRP levels and Pediatric Intensive Care Unit (PICU) mortality.
- To evaluate the prognostic value of these biomarkers compared to established severity scores.
Main Methods:
- Retrospective observational study of 152 critically ill pediatric patients undergoing CRRT.
- Measurement of PCT and CRP levels at CRRT initiation (T0) and 24 hours post-initiation (T24).
- Calculation of biomarker clearance, assessment of disease severity (PRISM-III, VIS), and logistic regression/ROC analysis for mortality prediction.
Main Results:
- PICU mortality rate was 36.8%.
- PCT levels were higher in non-survivors at T0 and T24, with significant decrease only in survivors. CRP showed no significant early changes.
- PCT at T24 had modest discriminative ability for mortality (AUC=0.663), while CRP performed poorly. VIS and PRISM-III remained independent predictors.
Conclusions:
- Early PCT and CRP kinetics within 24 hours of CRRT initiation have limited standalone prognostic value for pediatric critical care mortality.
- While PCT at 24 hours showed some association with mortality in unadjusted analysis, its discriminatory performance was modest.
- PCT and CRP should be interpreted as supportive biomarkers within the clinical context, not as replacements for established severity scores like PRISM-III and VIS.
Background:
Continuous renal replacement therapy (CRRT) may influence biomarker levels through extracorporeal clearance, complicating their interpretation in critically ill children. This study aimed to characterize the early kinetics of procalcitonin (PCT) and C-reactive protein (CRP) during the first 24 h after CRRT initiation and to evaluate their association with PICU mortality in critically ill children.
Methods:
This retrospective observational study included 152 critically ill pediatric patients undergoing CRRT. PCT and CRP levels were measured at CRRT initiation (T0) and at 24 h after CRRT initiation (T24). Biomarker clearance was calculated as the percentage change from T0 to T24. Disease severity was assessed using the Pediatric Risk of Mortality III (PRISM-III) score and vasoactive-inotropic score (VIS). Associations with mortality were analyzed using logistic regression, and predictive performance was evaluated using receiver operating characteristic (ROC) analysis.
Results:
PICU mortality was 36.8%. PCT levels were higher in non-survivors at CRRT initiation and at 24 h after CRRT initiation, with a more pronounced difference at 24 h (p = 0.017 and p < 0.001, respectively). PCT levels decreased significantly only in survivors. CRP levels showed no significant early changes in either group. PCT at 24 h after CRRT initiation demonstrated modest discriminative ability for mortality (AUC = 0.663), whereas CRP parameters showed lower performance. In multivariable analysis, VIS T24 and PRISM-III score remained independent predictors of mortality, while PCT did not retain independent significance.
Conclusions:
Early PCT and CRP kinetics during the first 24 h after CRRT initiation showed limited standalone prognostic value. PCT levels at 24 h were associated with mortality in unadjusted analyses, but their discriminatory performance was modest and they should be interpreted only as supportive biomarkers within the broader clinical context rather than as alternatives to established severity scores.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Chronic Kidney Disease III: Interprofessional Care